Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Switching Antipsychotic Medications
NCT00044655Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2001
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of risperidone, olanzapine, ziprasidone, quetiapine, aripiprazole in schizophrenia, schizoaffective disorder, sponsored by Icahn School of Medicine at Mount Sinai. Started Jul 2001; status: completed.
02
Drugs
risperidoneolanzapineziprasidonequetiapinearipiprazole
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00044655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044655.